XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense

   2020   2019 
General and administrative  $1,623,629   $357,318 
Research and development   212,341    134,431 
Total stock-based compensation expense  $1,835,970   $491,749 
Schedule of stock option plan activity
    Number of
Options
    Weighted
Average
Exercise
Price
    Weighted-
Average
Remaining
Contractual
Term (years)
    Aggregate
Intrinsic
Value(1)
 
Outstanding at September 30, 2018     368,216     $ 0.07       8.6     $ 820,862  
Granted     675,667     $ 2.32                
Exercised     (198,043 )   $ 0.27                
Forfeited/Cancelled         $                
Outstanding at September 30, 2019     845,840     $ 1.82       9.0     $ 343,406  
Granted     1,004,175     $ 2.06                
Exercised     (76,545 )   $ 0.04                
Forfeited/Cancelled     (294,985 )   $ 1.97                
Outstanding at September 30, 2020     1,478,485     $ 2.04       8.8     $ 96,088  
Vested and exercisable at September 30, 2020     761,998     $ 1.99       8.6     $ 96,088  

 

  (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of our common stock as of September 30, 2020 and 2019 of $1.29 and $1.87 per share, respectively. As of September 30, 2020, 1,401,940 and 685,453 outstanding and vested options, respectively, have no intrinsic value.
Schedule of weighted-average assumptions used black-scholes option-pricing model

   2020   2019 
Expected stock price volatility   53.1%   50.4%
Expected life of options (years)   5.6    5.6 
Expected dividend yield   0%   0%
Risk free interest rate   1.4%   2.4%